FDA commissioner Scott Gottlieb is continuing his plans to streamline and accelerate the regulators' practices, but now plans to close down at least one glaring loophole in the Orphan Drug
The government looks set to come under pressure to rethink moves to ration access to medicines, after a new plan from NICE and NHS England was criticised by industry representatives and oth